Delcath Systems Inc (DCTH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DCTH SEC filings page.
Delcath Systems Inc (DCTH) reported $95.4M in revenue over the twelve months to Jun 30, 2026, up 35.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
After years of losses, Delcath’s 2025 scale-up crossed into modest profitability while converting operations into cash with limited reinvestment.
Operating cash flow of$22.5M exceeded net income of$2.7M by more than eight times, showing that FY2025 cash generation was not dependent on reported earnings alone. Free cash flow of$21.0M stayed close to operating cash flow after only$1.5M of capital spending, pointing to a business that currently converts activity into cash without heavy reinvestment.
Revenue more than doubled to
The balance sheet shifted from a 2024 debt-free position to 2025 debt-to-equity of 0.1x, while current ratio remained 10.9x; this is a lightly leveraged structure with substantial current-asset coverage of short-term liabilities. Working-capital balances increased, yet operations produced
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Delcath Systems Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Delcath Systems Inc held $91.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $22.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Delcath Systems Inc scores 86/100 among other emerging companies.
Delcath Systems Inc had 35M shares outstanding at the end of fiscal year 2025, against 33M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Delcath Systems Inc scores 36/100 among other emerging companies.
Delcath Systems Inc spent $29.2M on research and development in fiscal year 2025, which was 34.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Delcath Systems Inc scores 67/100 among other emerging companies.
Delcath Systems Inc reported revenue of $85.2M in fiscal year 2025, against $37.2M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Delcath Systems Inc scores 96/100 among other emerging companies.
Delcath Systems Inc's operations generated $22.5M of cash in fiscal year 2025, against $18.7M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Delcath Systems Inc scores 94/100 among other emerging companies.
Delcath Systems Inc's cash, cash equivalents and investments came to $91.0M at the end of fiscal year 2025, against $12.4M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Delcath Systems Inc scores 93/100 among other emerging companies.
Delcath Systems Inc scores 21.53, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($533.0M) relative to total liabilities ($12.4M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Delcath Systems Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Delcath Systems Inc generates $8.34 in operating cash flow ($22.5M OCF vs $2.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Delcath Systems Inc generated $29.1M in revenue in Q2 2026. This represents an increase of 20.6% from the same quarter a year earlier. Against the prior quarter it is up 16.6%.
Delcath Systems Inc's EBITDA was $2.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.2% from the same quarter a year earlier. Against the prior quarter it is up 262.5%.
Delcath Systems Inc reported $2.7M in net income in Q2 2026. This represents a decrease of 1.1% from the same quarter a year earlier. Against the prior quarter it is up 349.3%.
Delcath Systems Inc earned $0.07 per diluted share (EPS) in Q2 2026. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 333.3%.
Cash & Balance Sheet
Delcath Systems Inc generated $5.2M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 24.5% from the same quarter a year earlier. Against the prior quarter it is up 1715.0%.
Delcath Systems Inc held $47.5M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Delcath Systems Inc's gross margin was 89.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.7 percentage points.
Delcath Systems Inc's operating margin was 8.2% in Q2 2026, reflecting core business profitability. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.8 percentage points.
Delcath Systems Inc's net profit margin was 9.2% in Q2 2026, showing the share of revenue converted to profit. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.4 percentage points.
Delcath Systems Inc's ROE was 2.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.
Capital Allocation
Delcath Systems Inc invested $10.4M in research and development in Q2 2026. This represents an increase of 50.8% from the same quarter a year earlier. Against the prior quarter it is up 5.7%.
Delcath Systems Inc spent $11K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 99.6%.
Delcath Systems Inc invested $503K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 26.4% from the same quarter a year earlier. Against the prior quarter it is down 11.8%.
DCTH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.1M+20.6% | $25.0M+26.3% | $20.7M+37.3% | $20.6M+83.6% | $24.2M+211.0% | $19.8M+530.3% | $15.1M+2701.5% | $11.2M+2480.6% |
| Cost of Revenue | $3.0M-10.0% | $3.7M+31.3% | $3.0M+41.6% | $2.6M+60.0% | $3.3M+118.4% | $2.8M+215.1% | $2.1M+1143.3% | $1.6M+1133.1% |
| Gross Profit | $26.1M+25.5% | $21.3M+25.5% | $17.7M+36.6% | $17.9M+87.6% | $20.8M+233.6% | $16.9M+657.6% | $13.0M+3425.5% | $9.6M+3076.1% |
| R&D Expenses | $10.4M+50.8% | $9.8M+96.2% | $9.4M+221.6% | $8.0M+106.6% | $6.9M+102.8% | $5.0M+35.3% | $2.9M-38.1% | $3.9M-17.1% |
| SG&A Expenses | $13.4M+17.7% | $13.1M+15.8% | $10.5M+50.0% | $10.3M+48.7% | $11.4M+68.0% | $11.3M+28.1% | $7.0M+0.8% | $7.0M+12.2% |
| Operating Income | $2.4M-7.5% | -$1.6M-355.0% | -$2.2M-171.9% | -$388K+69.2% | $2.6M+166.2% | $642K+106.2% | $3.0M+126.9% | -$1.3M+88.1% |
| EBITDA | $2.5M-7.2% | -$1.5M-324.1% | -$2.2M-174.4% | -$288K+75.2% | $2.7M+170.6% | $685K+106.7% | $2.9M+125.8% | -$1.2M+88.9% |
| Income Tax | $491K-3.3% | $162K-16.9% | $562K | -$455K | $508K | $195K | $0 | $0 |
| Net Income | $2.7M-1.1% | -$1.1M-200.1% | -$1.9M+44.2% | $830K-55.5% | $2.7M+119.6% | $1.1M+109.6% | -$3.4M+69.5% | $1.9M+109.2% |
| EPS (Basic) | $0.07-12.5% | -$0.03-200.0% | -$0.05+44.4% | $0.02-66.7% | $0.08+116.7% | $0.03+106.7% | -$0.09+72.7% | $0.06+105.3% |
| EPS (Diluted) | $0.070.0% | -$0.03-200.0% | -$0.05+44.4% | $0.02-66.7% | $0.07+114.6% | $0.03+106.7% | -$0.09+72.7% | $0.06 |
| Diluted Shares (Avg) | 40M-1.2% | 36M-8.8% | N/A | 40M+23.8% | 40M+41.9% | 40M+58.8% | N/A | 32M |
Not reported in any period shown, so not listed: Interest Expense.
DCTH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $137.0M+17.2% | $124.8M+43.0% | $123.6M+61.4% | $124.3M+292.3% | $116.9M+244.6% | $87.3M+141.9% | $76.6M+98.4% | $31.7M-33.4% |
| Current Assets | $130.5M+15.0% | $120.3M+42.6% | $119.5M+62.1% | $120.6M+317.6% | $113.5M+261.4% | $84.3M+150.7% | $73.8M+98.5% | $28.9M-37.3% |
| Cash & Equivalents | $47.5M+38.1% | $41.3M+223.4% | $43.5M+34.1% | $41.8M+402.9% | $34.4M+132.9% | $12.8M+8.6% | $32.4M+156.3% | $8.3M-79.4% |
| Short-Term Investments | $48.4M+3.9% | $48.0M+4.0% | $47.6M+128.5% | $47.1M+729.6% | $46.6M+809.1% | $46.1M+200.3% | $20.8M+5.1% | $5.7M |
| Inventory | $11.7M+11.3% | $9.8M+37.5% | $10.3M+47.9% | $10.7M+61.8% | $10.5M+66.6% | $7.1M+96.3% | $6.9M+108.7% | $6.6M+149.0% |
| Accounts Receivable | $15.9M+0.7% | $14.2M+1.6% | $11.7M+7.8% | $13.8M+98.3% | $15.8M+325.0% | $13.9M+791.4% | $10.9M+4418.7% | $6.9M+3283.4% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $15.9M+33.5% | $12.1M+71.1% | $12.4M+58.3% | $9.4M-59.1% | $11.9M-60.0% | $7.1M-67.0% | $7.8M-65.7% | $23.1M+1.1% |
| Current Liabilities | $13.3M+27.3% | $10.7M+102.3% | $10.9M+78.2% | $8.0M-62.9% | $10.4M-15.1% | $5.3M-60.4% | $6.1M-62.6% | $21.6M+54.5% |
| Non-Current Liabilities | $2.6M+78.3% | $1.4M-20.6% | $1.5M-13.9% | $1.4M-5.8% | $1.5M-91.7% | $1.8M-77.9% | $1.7M-73.4% | $1.5M-82.8% |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $2.0M |
| Total Equity | $121.1M+15.4% | $112.7M+40.5% | $111.2M+61.8% | $114.8M+1239.9% | $105.0M+2404.4% | $80.2M+448.8% | $68.7M+335.7% | $8.6M-65.3% |
| Retained Earnings | -$527.3M+0.1% | -$529.9M+0.1% | -$528.8M+0.5% | -$527.0M+0.2% | -$527.8M+0.4% | -$530.5M-2.8% | -$531.5M-5.2% | -$528.1M-6.9% |
Not reported in any period shown, so not listed: Goodwill.
DCTH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.7M-21.7% | $857K-61.1% | $8.2M+919.9% | $4.8M+231.1% | $7.3M+263.9% | $2.2M+123.0% | -$1.0M+87.7% | -$3.6M+60.3% |
| Depreciation & Amortization | $100K0.0% | $102K+137.2% | $80K+110.5% | $100K0.0% | $100K0.0% | $43K+48.3% | $38K-7.3% | $100K0.0% |
| Stock-Based Compensation | $5.1M-29.0% | $4.9M-27.9% | N/A | $5.6M+163.8% | $7.2M+134.9% | $6.9M+133.0% | N/A | $2.1M-24.3% |
| Capital Expenditures | $503K+26.4% | $570K+307.1% | $550K+140.2% | $459K+112.5% | $398K+294.1% | $140K+976.9% | $229K+1105.3% | $216K+21500.0% |
| Free Cash Flow | $5.2M-24.5% | $287K-86.1% | $7.7M+723.3% | $4.3M+211.9% | $6.9M+251.5% | $2.1M+121.5% | -$1.2M+84.9% | -$3.9M+57.9% |
| Investing Cash Flow | -$504K-21.4% | -$571K+97.7% | -$561K+96.3% | -$466K+33.1% | -$415K-104.0% | -$25.1M-639.7% | -$15.2M+22.6% | -$697K-69800.0% |
| Financing Cash Flow | $962K-93.4% | -$2.4M-173.2% | -$5.9M-114.7% | $3.1M+244.7% | $14.6M+612.9% | $3.3M-19.1% | $40.4M+4038400.0% | -$2.1M-106.1% |
| Share Buybacks | $11K | $3.0M | N/A | N/A | $0 | $0 | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
DCTH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8%+3.5pp | 85.0%-0.6pp | 85.5%-0.4pp | 87.2%+1.9pp | 86.3%+5.8pp | 85.6%+14.4pp | 85.9%+17.6pp | 85.4%+16.0pp |
| Operating Margin | 8.2%-2.5pp | -6.6%-9.8pp | -10.5%-30.7pp | -1.9%+9.3pp | 10.7%+61.1pp | 3.3% | 20.1% | -11.2% |
| Net Margin | 9.2%-2.0pp | -4.3%-9.7pp | -9.2%+13.4pp | 4.0%-12.6pp | 11.2% | 5.4% | -22.5% | 16.6% |
| Return on Equity | 2.2%-0.4pp | -0.9%-2.3pp | -1.7%+3.2pp | 0.7%-21.0pp | 2.6%+330.4pp | 1.3%+77.3pp | -4.9%+65.6pp | 21.8%+104.0pp |
| Return on Assets | 1.9%-0.4pp | -0.9%-2.1pp | -1.5%+2.9pp | 0.7%-5.2pp | 2.3%+42.8pp | 1.2%+32.0pp | -4.4%+24.4pp | 5.9%+48.6pp |
| Current Ratio | 9.83-1.0x | 11.24-4.7x | 10.92-1.1x | 15.06+13.7x | 10.88+8.3x | 15.95+13.4x | 12.01+9.7x | 1.34-2.0x |
| Debt-to-Equity | 0.130.0x | 0.110.0x | 0.11+0.1x | 0.08-0.2x | 0.11-1.0x | 0.09-0.4x | 0.00-0.6x | 0.23-0.7x |
| Asset Turnover | 0.210.0x | 0.200.0x | 0.170.0x | 0.17-0.2x | 0.210.0x | 0.23+0.1x | 0.20+0.2x | 0.35+0.3x |
| FCF Margin | 17.9%-10.7pp | 1.1%-9.3pp | 37.1%+45.3pp | 21.0%+55.4pp | 28.5%+87.1pp | 10.4% | -8.2% | -34.4% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Delcath Systems Inc DCTH | FY2025 | $85.2M | $2.7M | 3.2% | $533.0M | 79/100 |
| RxSight, Inc. RXST | FY2025 | $134.5M | -$39 | 0.0% | $200.1M | 73/100 |
| Senseonics Holdings, Inc. SENS | FY2025 | $35.3M | -$69.1M | N/A | $474.8M | 66/100 |
| CeriBell, Inc. CBLL | FY2025 | $89.1M | -$53.4M | -60.0% | $906.9M | 52/100 |
| Butterfly Network, Inc. BFLY | FY2025 | $97.6M | -$77.1M | -79.0% | $2.2B | 61/100 |
| Pacific Biosciences of California, Inc. PACB | FY2025 | $160.0M | -$546.4M | N/A | $724.2M | 49/100 |
Where Delcath Systems Inc Ranks
Frequently Asked Questions
What is Delcath Systems Inc's annual revenue?
Delcath Systems Inc (DCTH) reported $85.2M in total revenue for fiscal year 2025. This represents a 129.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Delcath Systems Inc's revenue growing?
Delcath Systems Inc (DCTH) revenue grew by 129.1% year-over-year, from $37.2M to $85.2M in fiscal year 2025.
Is Delcath Systems Inc profitable?
Yes, Delcath Systems Inc (DCTH) reported a net income of $2.7M in fiscal year 2025, with a net profit margin of 3.2%.
What is Delcath Systems Inc's EBITDA?
Delcath Systems Inc (DCTH) had EBITDA of $898K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Delcath Systems Inc's gross margin?
Delcath Systems Inc (DCTH) had a gross margin of 86.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Delcath Systems Inc's operating margin?
Delcath Systems Inc (DCTH) had an operating margin of 0.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Delcath Systems Inc's net profit margin?
Delcath Systems Inc (DCTH) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Delcath Systems Inc's return on equity (ROE)?
Delcath Systems Inc (DCTH) has a return on equity of 2.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Delcath Systems Inc's free cash flow?
Delcath Systems Inc (DCTH) generated $21.0M in free cash flow during fiscal year 2025. This represents a 209.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Delcath Systems Inc's operating cash flow?
Delcath Systems Inc (DCTH) generated $22.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Delcath Systems Inc's total assets?
Delcath Systems Inc (DCTH) had $123.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Delcath Systems Inc's capital expenditures?
Delcath Systems Inc (DCTH) invested $1.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Delcath Systems Inc spend on research and development?
Delcath Systems Inc (DCTH) invested $29.2M in research and development during fiscal year 2025.
What is Delcath Systems Inc's current ratio?
Delcath Systems Inc (DCTH) had a current ratio of 10.92 as of fiscal year 2025, which is generally considered healthy.
What is Delcath Systems Inc's debt-to-equity ratio?
Delcath Systems Inc (DCTH) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Delcath Systems Inc's return on assets (ROA)?
Delcath Systems Inc (DCTH) had a return on assets of 2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Delcath Systems Inc's P/E ratio?
Delcath Systems Inc (DCTH) has no price-to-earnings ratio at the moment: outside the range published as a multiple (on $532K net income, trailing 12 months to June 30, 2026). The market capitalization is $533.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Delcath Systems Inc's price-to-sales ratio?
Delcath Systems Inc (DCTH) trades at 5.6x sales, its market capitalization divided by revenue of $95.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $533.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Delcath Systems Inc's Altman Z-Score?
Delcath Systems Inc (DCTH) has an Altman Z-Score of 21.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Delcath Systems Inc's Piotroski F-Score?
Delcath Systems Inc (DCTH) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Delcath Systems Inc's earnings high quality?
Delcath Systems Inc (DCTH) has an earnings quality ratio of 8.34x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Delcath Systems Inc?
Delcath Systems Inc (DCTH) scores 79 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.